Antares Pharma, Inc. (NASDAQ:ATRS) today reported operating and financial results for the third quarter ended September 30, 2013.
Quarter and Recent Highlights
•Received approval from the U.S. Food and Drug Administration (FDA) for OTREXUP™.
Help employers find you! Check out all the jobs and post your resume.
